Evolutionary Genomics, Inc. Income Tax Expense
Evolutionary Genomics, Inc. reported Income Tax Expense of $0 for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2022-03-22
- Evolutionary Genomics, Inc. income tax expense (benefit) for the quarter ending 2021-03-31 was $0.00.
- Evolutionary Genomics, Inc. income tax expense (benefit) for the quarter ending 2020-12-31 was $0.00.
- Evolutionary Genomics, Inc. income tax expense (benefit) for the quarter ending 2020-09-30 was -$987.35K.
- Evolutionary Genomics, Inc. income tax expense (benefit) for the quarter ending 2020-03-31 was $0.00.
- Evolutionary Genomics, Inc. income tax expense (benefit) for fiscal 2020 was -$987.35K, a 3194.47% decline from fiscal 2019.
- Evolutionary Genomics, Inc. income tax expense (benefit) for fiscal 2019 was $31.91K.
- Evolutionary Genomics, Inc. income tax expense (benefit) for fiscal 2017 was -$530.24K.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 | $0.00 derived: sum of 2 quarters · filed 2022-03-22 | -$987.35K derived: sum of 3 quarters · filed 2022-03-22 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$987.35K derived: sum of 2 quarters · filed 2022-03-22 | -$987.35K 10-K · filed 2022-03-22 | |
| 2020-09-30 | -$987.35K 10-Q · filed 2021-11-01 | -$987.35K 10-Q · filed 2021-11-01 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $31.91K 10-K · filed 2021-03-31 | |||
| 2017-12-31 | -$530.24K 10-K · filed 2019-04-01 |